#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12680	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2149	584.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1397	1397	C	729	C	686	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22594	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3463	649.3	0	.	n	.	0	T695C	SNP	695	695	T	970	970	C	694	C	659	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22594	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3463	649.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1612	1612	A	687	A	650	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22594	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3463	649.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2246	2246	C	737	C,T,A	683,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22594	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3463	649.3	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2872	2872	T	674	T	642	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22594	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3463	649.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2320	2320	A	728	A	692	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	V36A	NONSYN	106	108	GTG	452	454	GCG	154;152;151	G;C;G	144;142;139	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	494	496	CGG	156;158;159	C;G;G	144;146;149	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	S68L	NONSYN	202	204	TCG	548	550	TTG	159;161;162	T,C;T,C;G	143,1;148,1;150	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	A90V	NONSYN	268	270	GCG	614	616	GTT	145;143;143	G;T,C;T,G	134;130,1;132,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	I105V	NONSYN	313	315	ATT	659	661	GTT	120;120;122	G;T;T	117;115;119	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	N125T	NONSYN	373	375	AAT	719	721	ACC	123;122;122	A;C;C	120;118;119	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	R135C	NONSYN	403	405	CGT	749	751	TGT	138;139;137	T;G;T	126;130;125	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	K151E	NONSYN	451	453	AAA	797	799	GAA	115;116;114	G,T;A;A	108,1;111;109	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	800	802	AAC	113;114;115	A;A;C	108;110;111	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	A172T	NONSYN	514	516	GCG	860	862	ACA	90;87;88	A;C;A	85;83;83	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	A175E	NONSYN	523	525	GCG	869	871	GAA	93;95;96	G;A;A	88;91;91	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	E176T	NONSYN	526	528	GAA	872	874	ACC	97;98;99	A;C;C	87;91;92	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	I178V	NONSYN	532	534	ATC	878	880	GTC	102;103;104	G;T;C	95;95;96	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	I188T	NONSYN	562	564	ATA	908	910	ACG	116;113;113	A;C;G,T	107;107;106,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	P200N	NONSYN	598	600	CCC	944	946	AAC	117;115;115	A;A;C	113;109;109	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1004	1006	TTG	125;125;124	T;T;G	116;117;118	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1061	1063	ACC	123;122;122	A;C;C	112;114;114	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1064	1066	GAC	123;124;126	G,A;A;C	110,1;110;116	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1073	1075	GCG	126;126;130	G;C;G	114;101;116	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1109	1111	GCT	108;109;107	G;C;T	103;104;100	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1350	folP	858	858	91.61	folP.l6.c30.ctg.1	1653	81.3	1	SNP	p	R230S	1	.	.	688	690	AGC	1034	1036	AGC	152;149;150	A;G;C	145;142;143	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3517	114.4	1	SNP	p	S91F	0	.	.	271	273	TCC	666	668	TCC	128;127;131	T;C;C	120;121;122	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3517	114.4	1	SNP	p	D95G	0	.	.	283	285	GAC	678	680	GAC	137;137;137	G;A;C	126;127;127	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4036	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3517	114.4	1	SNP	p	D95N	0	.	.	283	285	GAC	678	680	GAC	137;137;137	G;A;C	126;127;127	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1280	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1351	94.0	1	SNP	p	G45D	1	.	.	133	135	GAC	521	523	GAC	153;153;152	G;A;C	143;141;142	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	652	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1122	57.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4106	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3085	132.6	1	SNP	p	D86N	0	.	.	256	258	GAC	685	687	GAC	162;161;162	G;A;C	149;149;150	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4106	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3085	132.6	1	SNP	p	S87W	0	.	.	259	261	AGT	688	690	AGT	162;164;168	A,C;G;T	150,1;155;153	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4106	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3085	132.6	1	SNP	p	S87R	0	.	.	259	261	AGT	688	690	AGT	162;164;168	A,C;G;T	150,1;155;153	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4106	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3085	132.6	1	SNP	p	S87I	0	.	.	259	261	AGT	688	690	AGT	162;164;168	A,C;G;T	150,1;155;153	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4106	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3085	132.6	1	SNP	p	S88P	0	.	.	262	264	TCC	691	693	TCC	167;168;167	T;C;C	153;155;157	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3504	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2583	134.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1474	1476	GGC	167;167;165	G;G;C,T	158;157;155,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3276	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2497	130.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1313	1315	GCA	168;170;176	G;C;A	158;160;168	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3276	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2497	130.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1316	1318	ATC	175;178;181	A;T;C	167;166;172	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3276	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2497	130.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1328	1330	GTG	192;189;192	G;T;G	183;182;184	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3276	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2497	130.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1328	1330	GTG	192;189;192	G;T;G	183;182;184	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3276	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2497	130.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1832	1834	ACC	158;157;156	A;C;C	147;150;150	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3276	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2497	130.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1886	1888	GCG	143;143;143	G;C;G	127;119;125	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3276	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2497	130.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1886	1888	GCG	143;143;143	G;C;G	127;119;125	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3276	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2497	130.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2009	2011	GGC	132;130;131	G;G;C	123;120;118	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3276	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2497	130.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2018	2020	GGC	128;130;131	G;G;C	118;117;117	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3276	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2497	130.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2036	2038	CCG	115;114;113	C,G;C;G,C	86,3;84;83,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4818	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3075	156.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1794	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1884	94.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	610	610	C	116	C	109	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	G38E	NONSYN	112	114	GGA	332	334	GAA	185;183;185	G;A;A	177;175;176	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	S46G	NONSYN	136	138	AGC	356	358	GGC	177;175;173	G;G;C	169;166;165	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	E48G	NONSYN	142	144	GAA	362	364	GGA	172;175;178	G;G;A	161;164;166	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	T87A	NONSYN	259	261	ACT	479	481	GCT	163;164;167	G;C;T	156;157;161	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	485	487	AGC	168;167;165	A;G;C,T	162;163;159,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	577	578	CG	162;163	C;G	156;155	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	580	582	CAG	160;158;157	C;A;G	152;149;149	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	584	586	AAA	156;158;160	A;A;A	148;151;152	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	647	649	GAA	164;164;164	G;A;A	160;161;162	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	671	673	GCA	178;179;183	G;C;A	170;173;173	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	A215T	NONSYN	643	645	GCT	863	865	ACT	163;164;163	A,T;C,T;T	159,1;161,1;160	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	I218M	NONSYN	652	654	ATA	872	874	ATG	162;158;155	A,G;T;G,C	160,1;156;153,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	T256A	NONSYN	766	768	ACA	986	988	GCA	189;190;189	G;C;A	182;183;183	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	W257T	NONSYN	769	771	TGG	989	991	ACG	190;191;193	A;C;G	184;183;186	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	S258G	NONSYN	772	774	AGT	992	994	GGG	194;194;195	G;G;G	188;188;187	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	A259V	NONSYN	775	777	GCT	995	997	GTT	193;193;193	G;T;T	185;182;184	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1055	1057	GTA	212;211;204	G;T;A	196;197;191	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1094	1096	ACT	213;215;213	A;C;T	204;207;204	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1100	1102	GAT	222;219;216	G;A;T	214;210;208	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1112	1114	CAC	215;213;215	C;A;C	207;205;205	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	1	SNP	p	G120K	1	.	.	358	360	AAG	577	579	CGG	162;163;158	C;G;G	156;155;152	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	1	SNP	p	D121N	0	.	.	361	363	GAC	580	583	CGC	160;157;156	C;G;C	152;149;148	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2326	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1407	163.6	1	SNP	p	A121D	1	.	.	361	363	GAC	580	583	CGC	160;157;156	C;G;C	152;149;148	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	8762	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4937	176.9	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1946	1948	CAT	168;170;170	C,A;A;T	152,1;154;154	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	940	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1139	82.2	1	SNP	p	V57M	1	.	.	169	171	ATG	569	571	ATG	191;190;191	A;T;G	178;178;178	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
